| # | Title | Journal | Year | Citations |
|---|
| 1 | ARIA guideline 2019: treatment of allergic rhinitis in the German health system | Allergologie Select | 2019 | 70 |
| 2 | Systemic therapy of atopic dermatitis | Allergologie Select | 2017 | 55 |
| 3 | Janus kinase inhibitors for the therapy of atopic dermatitis | Allergologie Select | 2021 | 49 |
| 4 | Update of the S2k guideline on the management of IgE-mediated food allergies | Allergologie Select | 2021 | 42 |
| 5 | Guideline on allergen immunotherapy in IgE-mediated allergic diseases | Allergologie Select | 2022 | 39 |
| 6 | Epidemiology of cutaneous adverse drug reactions | Allergologie Select | 2017 | 38 |
| 7 | Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic | Allergologie Select | 2020 | 38 |
| 8 | Severe allergic reactions to the COVID-19 vaccine – statement and practical consequences | Allergologie Select | 2021 | 33 |
| 9 | COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) – A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergo | Allergologie Select | 2021 | 28 |
| 10 | Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics | Allergologie Select | 2020 | 26 |
| 11 | The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results | Allergologie Select | 2017 | 24 |
| 12 | Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA | Allergologie Select | 2020 | 23 |
| 13 | Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany | Allergologie Select | 2021 | 22 |
| 14 | Food-induced anaphylaxis and cofactors – data from the anaphylaxis registry | Allergologie Select | 2017 | 22 |
| 15 | Guideline on management of suspected adverse reactions to ingested histamine - Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergology and Environmental Medicine (GPA), the Medical Association | Allergologie Select | 2021 | 22 |
| 16 | GINIplus and LISAplus. Design and selected results of two German birth cohorts about natural course of atopic diseases and its determinants | Allergologie Select | 2017 | 20 |
| 17 | Allergy to pets and new allergies to uncommon pets | Allergologie Select | 2017 | 19 |
| 18 | Allergen-specific IgE: comparison between skin prick test and serum assay in real life | Allergologie Select | 2019 | 19 |
| 19 | Allergic contact dermatitis to rubber accelerators in protective gloves: Problems, challenges, and solutions for occupational skin protection | Allergologie Select | 2021 | 19 |
| 20 | Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis | Allergologie Select | 2021 | 16 |
| 21 | Implant allergy | Allergologie Select | 2017 | 15 |
| 22 | Allergic and intolerance reactions to wine | Allergologie Select | 2018 | 15 |
| 23 | Status report on the atopic dermatitis registry TREATgermany | Allergologie Select | 2021 | 14 |
| 24 | Atopic dermatitis and psychosocial comorbidities – What’s new? | Allergologie Select | 2020 | 14 |
| 25 | Obesity-associated asthma in childhood | Allergologie Select | 2020 | 14 |
| 26 | Biologics for atopic diseases: Indication, side effect management, and new developments | Allergologie Select | 2021 | 13 |
| 27 | Atopic eczema is an environmental disease | Allergologie Select | 2021 | 12 |
| 28 | Risk factors in Hymenoptera venom allergy | Allergologie Select | 2017 | 12 |
| 29 | Occupational contact allergy in bricklayers, tile setters etc. Current spectrum of sensitization and recent time trends | Allergologie Select | 2017 | 12 |
| 30 | Contact allergy to fragrances: current clinical and regulatory trends | Allergologie Select | 2017 | 11 |
| 31 | Molecular allergy diagnostic tests: development and relevance in clinical practice | Allergologie Select | 2017 | 11 |
| 32 | The influence of air pollution on pollen allergy sufferers | Allergologie Select | 2021 | 11 |
| 33 | Turning off the alarm – Targeting alarmins and other epithelial mediators of allergic inflammation with biologics | Allergologie Select | 2021 | 10 |
| 34 | A new era has begun: Treatment of atopic dermatitis with biologics | Allergologie Select | 2021 | 10 |
| 35 | Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy? | Allergologie Select | 2021 | 10 |
| 36 | Inhibition of cross-reactive carbohydrate determinants (CCDs) enhances the selectivity of in vitro allergy diagnosis | Allergologie Select | 2017 | 10 |
| 37 | Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions | Allergologie Select | 2022 | 10 |
| 38 | COVID-19 vaccination and allergen immunotherapy (AIT) - A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI) | Allergologie Select | 2021 | 9 |
| 39 | Workplace exposure to wood dust and the prevalence of wood-specific sensitization | Allergologie Select | 2018 | 9 |
| 40 | Anaphylaxis in middle-aged patients | Allergologie Select | 2021 | 8 |
| 41 | Cutaneous mastocytosis in childhood | Allergologie Select | 2022 | 8 |
| 42 | The role of the innate immune system in allergic contact dermatitis | Allergologie Select | 2017 | 7 |
| 43 | Use of biologics in allergen immunotherapy | Allergologie Select | 2021 | 7 |
| 44 | Anti-IgE: A treatment option in allergic rhinitis? | Allergologie Select | 2021 | 7 |
| 45 | Protein and DNA-based assays as complementary tools for fish allergen detection | Allergologie Select | 2017 | 7 |
| 46 | “New” inhalant plant allergens | Allergologie Select | 2020 | 7 |
| 47 | Nonpharmacological measures to prevent allergic symptoms in pollen allergy: A critical review | Allergologie Select | 2021 | 7 |
| 48 | Mechanisms in AIT: Insights 2021 | Allergologie Select | 2022 | 7 |
| 49 | 111 years of allergen-immunotherapy: A long and successful history of the only available disease-modifier in allergic diseases | Allergologie Select | 2022 | 7 |
| 50 | Benefits and limitations of sting challenge in hymenoptera venom allergy | Allergologie Select | 2021 | 6 |
